Preparing and adapting your immuno-oncology service for the future
With subcutaneous delivery, BiTE therapies and TIL services continuing to reshape pathways across the UK, this interactive online conference supported services to adapt quickly and confidently. The event brought together leading clinicians and service innovators from Immunotherapy MDTs across the NHS to share practical strategies that could be implemented immediately, from strengthening assessment and home treatment models to future-proofing workforce planning and service capacity.
Attendees explored what was working nationally, connected with peers facing similar challenges and left with clear next steps to develop and strengthen their services.
Following the success of previous collaborative conferences with the IOCN in Coventry (October 2024) and Leeds (July 2025), this 2026 online meeting continued the partnership and provided another valuable opportunity for shared learning and innovation.
With thanks to our collaborator and supporter:
.png)
5 hours CPD
This online conference offered practical learning grounded in real-world service development. Through expert-led presentations and structured discussion, attendees explored current priorities, emerging treatments and the evolving demands on immuno-oncology services. Participants gained clearer insight into how to strengthen and develop their pathways in 2026 and beyond.
Key learning areas included national immuno-oncology developments and pathway priorities, the evolving role of subcutaneous immunotherapy delivery and associated safety considerations, BiTE pathway developments and the management of complex immunosuppression, and TIL therapy developments and their implications for both TIL and non-TIL sites.
Attendees also explored the design and delivery of safe immuno-oncology home treatment services, strengthened approaches to assessment, escalation and discharge processes, considered the integration of palliative care within immuno-oncology pathways, and reviewed how established services could be developed to meet increasing demand.
Online networking
This dedicated training day provided structured time for attendees to strengthen their immuno-oncology services and reflect on future development priorities.
Participants built professional networks by connecting with immuno-oncology clinicians, nurses, pharmacists and service leads to share approaches, challenges and practical solutions. They developed their knowledge by examining key issues shaping evolving immuno-oncology pathways, including new treatment models, monitoring requirements and service pressures.
The day also supported service development by giving attendees the opportunity to step away from day-to-day pressures, review their current pathways, explore alternative delivery models and identify realistic actions to improve capacity and sustainability.
With thanks to our partner
This online conference was created in collaboration with and through support from IOCN.
.png)
Learning & development
Oncology National Networking Forums are pleased to be featured on the ACCEND Greater Manchester ePortfolio
The ePortfolio platform is available via the Greater Manchester Cancer Academy and supports professional development in cancer care.
This forum and all of our events are mapped to the ACCEND Framework and can be recorded in the Greater Mancester ePortfolio to help you evidence your learning, reflections and competencies.
To find out more, click on the ACCEND tab.
| 9:30 |
Registration, technical support and networking opportunity
|
| 10:00 |
Introduction, instructions and course leader’s opening remarks
Dr Anna Olsson-Brown, Consultant in Medical Oncology and Clinical Director for Clinical Cancer Care, University Hospitals Sussex NHS Foundation Trust
|
| IO Developments | |
| 10:10 |
National landscape priorities and update: Immuno-Oncology developments
Dr Anna Olsson-Brown, Consultant in Medical Oncology and Clinical Director for Clinical Cancer Care, University Hospitals Sussex NHS Foundation Trust
|
| Subcutaneous delivery | |
| 10:35 |
Exploring the evolving role of subcutaneous delivery in immuno-oncology
Katie Hemer, Lead SACT Nurse, Clatterbridge Cancer Centre, Clatterbridge Cancer Centre NHS Foundation Trust
|
| 11:00 |
Questions and answers with your speakers
|
| 11:10 |
Screen break
|
| BiTE pathways | |
| 11:20 |
Developments in BiTE pathways and managing complex immunosuppression
Elilta Samuel, Specialist Haemato-oncology Pharmacist, The Royal Marsden NHS Foundation Trust
|
| TILs service update | |
| 11:45 |
Developments in tumour infiltrating lymphocyte (TIL) therapy services
Dr Andrew Furness, Consultant Medical Oncologist and Solid Tumour Cellular Therapy Lead, The Royal Marsden NHS Foundation Trust
|
| 12:20 |
Questions and answers with your speakers
|
| 12:30 |
Lunch break
|
| Home treatment | |
| 1:00 |
Designing and delivering an IO home treatment service
Joanne Upton, Chief Patient Officer and Hollie Murphy, Head of Cancer Services, Lloyds Clinical
|
| 1:25 |
Questions and answers with your speaker
|
| 1:35 |
Interactive discussion: Implementing immuno-oncology home treatment
|
| Improving assessment | |
| 2:00 |
Practical assessment of patients on immuno-oncology
Ali Hodge, Nurse Consultant Immunotherapy, University Hospitals Sussex NHS Foundation Trust
|
| 2:25 |
Questions and answers with your speaker
|
| 2:35 |
Screen break
|
| Working with end-of-life care | |
| 2:45 |
Integrating palliative care and hospice support into IO pathways
Jordan Cox, Oncology Palliative Care Nurse, University Hospitals Sussex NHS Foundation Trust
|
| Service re-evaluation | |
| 3:10 |
Conducting timely and effective immuno-oncology service re-evaluation
Trudy Guinian, Immuno-Oncology Nurse Consultant, Clatterbridge Cancer Centre NHS Foundation Trust
|
| 3:25 |
Questions and answers with your speakers
|
| 3:35 |
Interactive discussion: Developing your services and determining your next steps
|
| 4:00 |
Chair’s closing remarks and close of day
|
With thanks to the speakers
Attendees learned from those shaping immuno-oncology services at a national and regional level. The expert speaker line-up brought together leading clinicians, service innovators and specialists who shared their knowledge, experience and practical insights to support the ongoing development of immuno-oncology pathways.
Dr Anna Olsson-Brown
Consultant in Medical Oncology and Clinical Director for Clinical Cancer Care
University Hospitals Sussex NHS Foundation Trust
Katie Hemer
Lead SACT Nurse, Clatterbridge Cancer Centre
Clatterbridge Cancer Centre NHS Foundation Trust
Elilta Samuel
Specialist Haemato-oncology Pharmacist
The Royal Marsden NHS Foundation Trust
Dr Andrew Furness
Consultant Medical Oncologist and Solid Tumour Cellular Therapy Lead
The Royal Marsden NHS Foundation Trust
Joanne Upton
Chief Patient Officer
Lloyds Clinical
Hollie Murphy
Head of Cancer Services
Lloyds Clinical
Ali Hodge
Nurse Consultant Immunotherapy
University Hospitals Sussex NHS Foundation Trust
Jordan Cox
Oncology Palliative Care Nurse
University Hospitals Sussex NHS Foundation Trust
Trudy Guinian
Immuno-Oncology Nurse Consultant
Clatterbridge Cancer Centre NHS Foundation Trust
Supported by IOCN
With thanks to our online conference supporter IOCN.
The Immuno-Oncology Clinical Network was established in 2022 by Dr Anna Olsson-Brown and a team of trustees with a passion for improving the care of cancer patients receiving immunotherapy treatment. Dr Olsson-Brown recognised the need to build a multi-disciplinary and multi-specialty community to support healthcare professionals to manage the complexities of Immuno-Oncology treatments including the autoimmune side effects. The Immuno-Oncology Clinical Network applied for charitable status in Spring 2023.
Who came?
This online conference was tailored for NHS professionals working within Immunotherapy MDTs, including but not limited to:
- Lead Nurses, CNS, Matrons and Sisters in Cancer, Acute Oncology, Immunotherapy, Chemotherapy, CUP, Rapid Diagnostics and Haematology
- Clinical Nurse Specialists and Consultants in Pain Management and Palliative Care
- Consultant Clinical Oncologists, Consultant Medical Oncologists and Specialist Doctors
- Pharmacists, Medical Managers and Service Managers
Past attendee feedback
This online conference was organised in collaboration with the IOCN, building on the success of the Practical Management of Immuno-Oncology: Service Development event held on 24th October 2024 in Coventry and Immuno-Oncology Service Delivery: Capacity Management held on Friday 11th July 2025 in Leeds. See what attendees had to say about our previous meetings:
About the ACCEND Framework
The ACCEND Framework is designed to enhance cancer care by providing a structured approach to education and professional development for healthcare professionals.
- It defines the essential Cancer Capabilities in Practice (CiPs) and offers a tailored educational structure to support progression at every stage of a cancer care career.
- Launched in January 2023, the framework aims to transform career pathways and improve training and development opportunities across the cancer workforce.
- It provides access to the education and training needed to meet role-specific competencies and includes dedicated resources for nurses, allied health professionals and those in cancer-related support roles.
- The ACCEND Framework delivers a nationally agreed career and education structure underpinned by clearly defined capabilities in practice.
Map your learning
All Oncology National Networking Forum courses listed on the ACCEND Greater Manchester ePortfolio are fully aligned with the ACCEND Framework.
You can easily log your attendance and map your learning to the Cancer Capabilities in Practice (CiPs) through the ACCEND Greater Manchester ePortfolio.
To do this:
- Register and log in to the Greater Manchester ePortfolio
- Click ‘Add Entry’
- Select 'Choose an item from the library'
- Change the provider to Oncology National Networking Forums
- Choose the relevant event you have attended (or plan to attend)
This tool offers a central space to track your professional development, reflections and achievements - supporting your ongoing career in cancer care.
Click here to access the Greater Manchester ePortfolio
Sponsorship engagement
Our role at SBK Healthcare is to bring industry together with healthcare professionals so that you can educate and inform your audience. These trail-blazing oncology delivery forums offer dedicated presentations, Q&A, networking and discussion time, each sponsor will be fully immersed into the event and able to effectively engage with your NHS audience.
Your event, managed by us
SBK Healthcare also provides in-house forums. Working closely with you as the client we can research, produce, market and deliver the conference or online forum that best suits the audience and meets your goals.
Reach out today
If you would like more information on our sponsorship options an in-house forum or if you wish to discuss your needs and what solutions may be appropriate for your business, please contact:
Vanessa Jarman
Contact: 01732 897788
Email: Vanessa.Jarman@sbk-healthcare.co.uk